The Importance of a Serum-Free, Chemically-Defined Manufacturing Workflow for T Cell Therapy

Explore the critical role of serum-free, chemically-defined manufacturing processes in T cell therapy development through this 15-minute webinar presented by Dr. Sam Bhattacharya, Product Manager for Cell Culture Applications at BioLegend. Learn about the complex biomanufacturing challenges facing cell-based therapies, which represent advanced medical treatments for cancers and other diseases using immune cells from patients (autologous) or healthy donors (allogeneic). Discover how these immune cells undergo activation, expansion, and ex vivo genetic modification as part of the therapeutic process. Understand the importance of establishing robust and well-characterized biomanufacturing processes to meet the growing demand for these promising therapies, while addressing the inherent complexity and costs associated with developing safe, high-efficacy cell therapy products. Gain insights from Dr. Bhattacharya's extensive background in immunology, CRO/CDMO industry experience, and current expertise in GMP product management for cell culture applications.